Orthopedics Medical News about Giant Cell Tumors

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rare site giant cell tumors: report of two cases on phalanges of the finger and review of literature
Journal of Orthopaedics and Traumatology, 10/09/09

Saikia KC et al. – The authors report two cases of GCT arising from a phalanx of a finger. One case presented with recurrence following the amputation of the left ring finger. He was treated successfully with ray amputation. The other case was treated primarily by intralesional curettage and autogenous bone graft. At their most recent follow–ups, both were recurrence free and had returned to their previous occupational and recreational activities.

<< Previous
Influence of aquatic training on the motor performance of...

Next >>
Recent studies on the genetic basis of ankylosing spondylitis

Giant cell angiitis of the central nervous system with atypical presentation
Neuropathology, 11/20/09 Relevance Score: 82%

Giant cell tumor of the extremity: A review of 349 cases from a single institution
Cancer Treatment Reviews, 11/05/09 Relevance Score: 81%

Giant Cell Angiofibroma, A Variant of Solitary Fibrous Tumor, of the Orbit in a 16-Year-Old Girl
Ophthalmic Plastic and Reconstructive Surgery, 10/07/09 Relevance Score: 81%

Giant cell tumor of the patella and its management using a patella, patellar tendon, and tibial tubercle allograft
Knee Surgery, Sports Traumatology, Arthroscopy, 10/05/09 Relevance Score: 81%

Interventions for central giant cell granuloma (CGCG) of the jaws
Cochrane Reviews, 10/27/09 Relevance Score: 80%